Validation of the World Health Organization quality of life instrument in patients with HIV infection

Quality of Life Research

Volumn 11, Issue 8, 2002, Pages 753-762

  Fang, C T ^a   Hsiung, P C ^b   Yu, C F ^c   Chen, M Y ^a   Wang, Jung Der ^a,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Human immunodeficiency virus infection; Quality of life; WHOQOL

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FACTORIAL ANALYSIS; FEMALE; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SELF EVALUATION; SOCIAL ASPECT; WORLD HEALTH ORGANIZATION; WORLD HEALTH ORGANIZATION QUALITY OF LIFE;

ADULT; FEMALE; HEALTH STATUS; HIV INFECTIONS; HUMANS; MALE; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; TAIWAN; WORLD HEALTH ORGANIZATION;

EID: 0036891691     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020870402019     Document Type: Article

References (41)

1. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-860.
2. Wu AW. Quality of life assessment comes of age in the era of highly active antiretroviral therapy. AIDS 2000; 14: 1449-1451.
3. Hays RD, Cunningham WE, Sherbourne CD, et al. Health-related quality of life in patients with human immunodeficiency virus infection in the United States: Results from the HIV Cost and Services Utilization Study. Am J Med 2000; 108: 714-722.
4. Cunningham WE, Shapiro MF, Hays RD, et al. Constitutional symptoms and health-related quality of life in patients with symptomatic HIV disease. Am J Med 1998; 104: 129-136.
5. Lorenz KA, Shapiro MF, Asch SM, Bozzette SA, Hays RD. Associations of symptoms and health-related quality of life: Findings from a national study of persons with HIV infection. Ann Intern Med 2001; 134: 854-860.
6. Bing EG, Hays RD, Jacobson LP, et al. Health-related quality of life among people with HIV disease: Results from the Multicenter AIDS Cohort Study. Qual Life Res 2000; 9: 55-63.
7. Low-Beer S, Chart K, Wood E, et al. Health-related quality of life among persons with HIV after the use of protease inhibitors. Qual Life Res 2000; 9: 941-949.
8. Osowiecki DM, Cohen RA, Morrow KM, et al. Neurocognitive and psychological contributions to quality of life in HIV-1-infected women. AIDS 2000; 14: 1327-1332.
9. Weinfurt KP, Willke RJ, Glick HA, Freimuth WW, Schulman KA. Relationship between CD4 count, viral burden, and quality of life over time in HIV-1-infected patients. Med Care 2000; 38: 404-410.
10. Call SA, Klapow JC, Stewart KE, et al. Health-related quality of life and virologic outcomes in an HIV clinic. Qual Life Res 2000; 9: 977-985.
11. Nieuwkerk PT, Gisolf EH, Colebunders R, Wu AW, Danner SA, Sprangers MA. Quality of life in asymptomatic and symptomatic HIV-infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group. AIDS 2000; 14: 181-187.
12. Nieuwkerk PT, Gisolf EH, Reijers MH, Lange JM, Danner SA, Sprangers MA. Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection. AIDS 2001; 15: 1985-1991.
13. Bucciardini R, Wu AW, Floridia M, et al. Quality of life outcomes of combination zidovudine-didanosine-nevirapine and zidovudine-didanosine for antiretroviral-naive advanced HIV-infected patients. AIDS 2000; 14: 2567-2574.
14. Freedberg KA, Losina E, Weinstein MC, et al. The cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med 2001; 344: 824-831.
15. Schackman BR, Goldie SJ, Weinstein MC, Losina E, Zhang H, Freedberg KA. Cost-effectiveness of earlier initiation of antiretroviral therapy for uninsured HIV-infected adults. Am J Public Health 2001; 91: 1456-1463.
16. Smith MY, Feldman J, Kelly P, DeHovitz JA, Chirgwin K, Minkoff H. Health-related quality of life of HIV-infected women: Evidence for the reliability, validity and responsiveness of the Medical Outcomes Study Short-Form 20. Qual Life Res 1996; 5: 47-55.
17. Wachtel T, Piette J, Mor V, Stein M, Fleishman J, Carpenter C. Quality of life in persons with human immunodeficiency virus infection: Measurement by the Medical Outcomes Study instrument. Ann Intern Med 1992; 116: 129-137.
18. Wu AW, Revicki DA, Jacobson D, Malitz FE. Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res 1997; 6: 481-493.
19. Anderson JP, Kaplan RM, Coons SJ, Schneiderman LJ. Comparison of the Quality of Well-being Scale and the SF-36 results among two samples of ill adults: AIDS and other illnesses. J Clin Epidemiol 1998; 51: 755-762.
20. Kaplan RM, Anderson JP, Patterson TL, et al. Validity of the Quality of Well-Being Scale for persons with human immunodeficiency virus infection. Psychosom Med 1995; 57: 138-147.
21. Leplege A, Rude N, Ecosse E, Ceinos R, Dohin E, Pouchot J. Measuring quality of life from the point of view of HIV-positive subjects: The HIV-QL31. Qual Life Res 1997; 6: 585-594.
22. Holmes WC, Shea JA, A new HIV/AIDS-targeted quality of life (HAT-QoL) instrument: Development, reliability, and validity. Med Care 1998; 36: 138-154.
23. Lubeck DP, Fries JF. Assessment of quality of life in early stage HIV-infected persons: Data from the AIDS Time-oriented Health Outcome Study (ATHOS). Qual Life Res 1997; 6: 494-506.
24. De Boer JB, Sprangers MA, Aaronson NK, Lange JM, van Dam FS. A study of the reliability, validity and responsiveness of the HIV overview of problems evaluation system (HOPES) in assessing the quality of life of patients with AIDS and symptomatic HIV infection. Qual Life Res 1996; 5: 339-347.
25. Smith KW, Avis NE, Mayer KH, Swislow L. Use of the MQoL-HIV with asymptomatic HIV-positive patients. Qual Life Res 1997; 6: 555-560.
26. Peterman AH, Cella D, Mo F, McCain N. Psychometric validation of the revised Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument. Qual Life Res 1997; 6: 572-584.
27. Thumboo J, Fong KY, Ng TP, et al. Validation of the MOS SF-36 for quality of life assessment of patients with systemic lupus erythematosus in Singapore. J Rheumatol 1999; 26: 97-102.
28. WHOQOL Group. The development of the World Health Organization Quality of Life Assessment Instrument (the WHOQOL). In: Orley J, Kuyken W (eds), Quality of Life Assessment: International Perspectives. New York: Springer-Verlag, 1994.
29. WHOQOL Group. The World Health Organization quality of life assessment (WHOQOL): Development and general psychometric properties. Soc Sci Med 1998; 46: 1569-1585.
30. Bonomi AE, Patrick DL, Bushnell DM, Martin M. Validation of the United States' version of the World Health Organization Quality of Life (WHOQOL) instrument. J Clin Epidemiol 2000; 53: 1-12.
31. WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998; 28: 551-558.
32. The WHOQOL-Taiwan Group. The User's Manual of the Development of the WHOQOL-BREF Taiwan Version. 1st Edn., Taiwan, Taipei, 2000.
33. Holzemer WL, Henry SB, Nokes KM, et al. Validation of the sign and symptom check-list for persons living with HIV disease (SSC-HIV). J Adv Nurs 1999; 30: 1041-1049.
34. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41(RR-17): 1-19.
35. Nunnally JC. Psychometric Theory. New York: McGraw-Hill, 1967: 226.
36. Hays RD, Anderson RT, Revicki D. Assessing reliability and validity of measurement in clinical trials. In: Staquet MJ, Hays RD, Fayers PM (eds), Quality of Life Assessment in Clinical Trials: Methods and Practice. New York: Oxford University Press, 1998: 174-175.
37. Prisant LM, Carr AA, Bottini PB, Thompson WO, Rhoades RB. Repeatability of automatic ambulatory blood pressure measurements. J Family Practice 1992; 34: 569-574.
38. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622-629.
39. Aaronson NK, Bullinger M, Ahmedzai S. A modular approach to quality-of-life assessment in cancer clinical trials. Recent Results Cancer Res 1988; 111: 231-249.
40. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376.
41. Sprangers MA, Cull A, Groenvold M, Bjordal K, Blazeby J, Aaronson NK. The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: An update and overview. EORTC Quality of Life Study Group. Qual Life Res 1998; 7: 291-300.